Author name: Publisher

Wondering whether McKesson at around US$860 a share still offers value or is pricing in most of its strengths already? […]

Wondering if Abbott Laboratories at around US$103.99 is priced for opportunity or risk? This article focuses squarely on what the

Novo Nordisk (NYSE:NVO) has received an FDA National Priority Voucher tied to a higher dose of its obesity drug Wegovy.

Wondering if Deere at US$566.64 still offers value, or if most of the opportunity is already priced in. The stock’s

Wondering if Volkswagen at €86.48 is a potential bargain or a value trap? This article breaks down what the current

Wondering if Yum! Brands at around US$153.96 is still a fair deal or starting to look stretched? This article walks

If you are wondering whether Arista Networks’ current share price lines up with its underlying value, you are not alone.